PT - JOURNAL ARTICLE AU - Deanna L. Hubbard AU - Diana G. Wilkins AU - Douglas E. Rollins TI - The Incorporation of Cocaine and Metabolites into Hair: Effects of Dose and Hair Pigmentation DP - 2000 Dec 01 TA - Drug Metabolism and Disposition PG - 1464--1469 VI - 28 IP - 12 4099 - http://dmd.aspetjournals.org/content/28/12/1464.short 4100 - http://dmd.aspetjournals.org/content/28/12/1464.full SO - Drug Metab Dispos2000 Dec 01; 28 AB - The relationship between xenobiotic concentrations in hair and the degree of systemic xenobiotic exposure is poorly defined. The purpose of this study was to evaluate the effect of dose, time, and pigment on the hair incorporation of cocaine (COC) and its metabolites, benzoylecgonine (BE), ecgonine methyl ester (EME), and norcocaine (NCOC). COC was administered by the i.p. route to male Long-Evans (LE) rats at three doses (5, 10, and 20 mg/kg) once daily for 5 days. Fourteen days after the initial injection, the hair was collected and analyzed by gas chromatography/mass spectrometry for the compounds of interest. COC, EME, and NCOC were preferentially incorporated into pigmented hair in a dose-dependent manner. None of the analytes were detected in nonpigmented hair. The plasma pharmacokinetic profile of each analyte was determined at each dose. After normalizing for the plasma concentrations, the incorporation of COC into pigmented hair was 2 orders of magnitude greater than BE. The time course of COC and metabolite distribution into hair was also investigated from 1 h to 14 days after a single dose. After COC disappears from plasma, there is a 3-day delay before maximal hair concentrations are reached in pigmented hair. In nonpigmented hair, concentrations of BE and COC did not exceed 0.25 ng/mg and were undetectable after 4 h and 2 days, respectively. This study demonstrates that the pigment-mediated differences in the incorporation of COC and its metabolites noted at 14 days after dosing are also evident a few hours after drug administration. The American Society for Pharmacology and Experimental Therapeutics